熱門資訊> 正文
Singular Genomics将被Deerfield收购
2024-12-23 22:22
- Deerfield Management Company is acquiring Singular Genomics (NASDAQ:OMIC) in an ell-cash deal for $20 a share.
- Deerfield said the amount is a 254% premium over Singular's closing price on Sept. 12, when the investment firm first publicly disclosed its acquisition proposal. Singular shares closed Dec. 20 at $19.55
- Singular's board has approved the transaction, which is expected to close in H1 2025.
More on Singular Genomics
- Seeking Alpha’s Quant Rating on Singular Genomics Systems
- Historical earnings data for Singular Genomics Systems
- Financial information for Singular Genomics Systems
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。